The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Hypercholesterolemia Treatment-Global Market Insights and Sales Trends 2024

Hypercholesterolemia Treatment-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1863592

No of Pages : 85

Synopsis
Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. Presence of low-density Lipoprotein Cholesterol (LDL-C) or bad cholesterol in the blood, may lead to cardiovascular diseases. Hypercholesterolemia is caused due to a combination of genetic and environmental factors. Environmental factors include excessive diet intake and obesity. In case of genetic factors, the number of copies of the gene determines the severity of the disease. People with the homozygous form (two copies of the gene) generally suffer from severe cardiovascular diseases during childhood, while those with the heterozygous form (with a single copy of the gene) suffer from heart diseases in their 30s or 40s.
The global Hypercholesterolemia Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hypercholesterolemia Treatment in various end use industries. The expanding demands from the Clinic, Hospital and Others,, are propelling Hypercholesterolemia Treatment market. AEM-2802, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the AEM-2814 segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hypercholesterolemia Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hypercholesterolemia Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hypercholesterolemia Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hypercholesterolemia Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hypercholesterolemia Treatment covered in this report include CymaBay Therapeutics Inc, Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc, Regeneron Pharmaceuticals Inc, RegenxBio Inc and The Medicines Company, etc.
The global Hypercholesterolemia Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CymaBay Therapeutics Inc
Daewoong Co Ltd
Gemphire Therapeutics Inc
LipimetiX Development Inc
Regeneron Pharmaceuticals Inc
RegenxBio Inc
The Medicines Company
Global Hypercholesterolemia Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hypercholesterolemia Treatment market, Segment by Type:
AEM-2802
AEM-2814
Alirocumab
Evinacumab
Others
Global Hypercholesterolemia Treatment market, by Application
Clinic
Hospital
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hypercholesterolemia Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Hypercholesterolemia Treatment
1.1 Hypercholesterolemia Treatment Market Overview
1.1.1 Hypercholesterolemia Treatment Product Scope
1.1.2 Hypercholesterolemia Treatment Market Status and Outlook
1.2 Global Hypercholesterolemia Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hypercholesterolemia Treatment Market Size by Region (2018-2029)
1.4 Global Hypercholesterolemia Treatment Historic Market Size by Region (2018-2023)
1.5 Global Hypercholesterolemia Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hypercholesterolemia Treatment Market Size (2018-2029)
1.6.1 North America Hypercholesterolemia Treatment Market Size (2018-2029)
1.6.2 Europe Hypercholesterolemia Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Hypercholesterolemia Treatment Market Size (2018-2029)
1.6.4 Latin America Hypercholesterolemia Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Hypercholesterolemia Treatment Market Size (2018-2029)
2 Hypercholesterolemia Treatment Market by Type
2.1 Introduction
2.1.1 AEM-2802
2.1.2 AEM-2814
2.1.3 Alirocumab
2.1.4 Evinacumab
2.1.5 Others
2.2 Global Hypercholesterolemia Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hypercholesterolemia Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Hypercholesterolemia Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hypercholesterolemia Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hypercholesterolemia Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hypercholesterolemia Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hypercholesterolemia Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hypercholesterolemia Treatment Revenue Breakdown by Type (2018-2029)
3 Hypercholesterolemia Treatment Market Overview by Application
3.1 Introduction
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Hypercholesterolemia Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hypercholesterolemia Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Hypercholesterolemia Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hypercholesterolemia Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hypercholesterolemia Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hypercholesterolemia Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hypercholesterolemia Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hypercholesterolemia Treatment Revenue Breakdown by Application (2018-2029)
4 Hypercholesterolemia Treatment Competition Analysis by Players
4.1 Global Hypercholesterolemia Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hypercholesterolemia Treatment as of 2022)
4.3 Date of Key Players Enter into Hypercholesterolemia Treatment Market
4.4 Global Top Players Hypercholesterolemia Treatment Headquarters and Area Served
4.5 Key Players Hypercholesterolemia Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Hypercholesterolemia Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 CymaBay Therapeutics Inc
5.1.1 CymaBay Therapeutics Inc Profile
5.1.2 CymaBay Therapeutics Inc Main Business
5.1.3 CymaBay Therapeutics Inc Hypercholesterolemia Treatment Products, Services and Solutions
5.1.4 CymaBay Therapeutics Inc Hypercholesterolemia Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 CymaBay Therapeutics Inc Recent Developments
5.2 Daewoong Co Ltd
5.2.1 Daewoong Co Ltd Profile
5.2.2 Daewoong Co Ltd Main Business
5.2.3 Daewoong Co Ltd Hypercholesterolemia Treatment Products, Services and Solutions
5.2.4 Daewoong Co Ltd Hypercholesterolemia Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Daewoong Co Ltd Recent Developments
5.3 Gemphire Therapeutics Inc
5.3.1 Gemphire Therapeutics Inc Profile
5.3.2 Gemphire Therapeutics Inc Main Business
5.3.3 Gemphire Therapeutics Inc Hypercholesterolemia Treatment Products, Services and Solutions
5.3.4 Gemphire Therapeutics Inc Hypercholesterolemia Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 LipimetiX Development Inc Recent Developments
5.4 LipimetiX Development Inc
5.4.1 LipimetiX Development Inc Profile
5.4.2 LipimetiX Development Inc Main Business
5.4.3 LipimetiX Development Inc Hypercholesterolemia Treatment Products, Services and Solutions
5.4.4 LipimetiX Development Inc Hypercholesterolemia Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 LipimetiX Development Inc Recent Developments
5.5 Regeneron Pharmaceuticals Inc
5.5.1 Regeneron Pharmaceuticals Inc Profile
5.5.2 Regeneron Pharmaceuticals Inc Main Business
5.5.3 Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Products, Services and Solutions
5.5.4 Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Regeneron Pharmaceuticals Inc Recent Developments
5.6 RegenxBio Inc
5.6.1 RegenxBio Inc Profile
5.6.2 RegenxBio Inc Main Business
5.6.3 RegenxBio Inc Hypercholesterolemia Treatment Products, Services and Solutions
5.6.4 RegenxBio Inc Hypercholesterolemia Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 RegenxBio Inc Recent Developments
5.7 The Medicines Company
5.7.1 The Medicines Company Profile
5.7.2 The Medicines Company Main Business
5.7.3 The Medicines Company Hypercholesterolemia Treatment Products, Services and Solutions
5.7.4 The Medicines Company Hypercholesterolemia Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 The Medicines Company Recent Developments
6 North America
6.1 North America Hypercholesterolemia Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hypercholesterolemia Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hypercholesterolemia Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hypercholesterolemia Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hypercholesterolemia Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hypercholesterolemia Treatment Market Dynamics
11.1 Hypercholesterolemia Treatment Industry Trends
11.2 Hypercholesterolemia Treatment Market Drivers
11.3 Hypercholesterolemia Treatment Market Challenges
11.4 Hypercholesterolemia Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’